Your browser doesn't support javascript.
loading
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.
Chamseddine, Shadi; Mohamed, Yehia I; Lee, Sunyoung S; Yao, James C; Hu, Zishuo Ian; Tran Cao, Hop S; Xiao, Lianchun; Sun, Ryan; Morris, Jeffrey S; Hatia, Rikita I; Hassan, Manal; Duda, Dan G; Diab, Maria; Mohamed, Amr; Nassar, Ahmed; Datar, Saumil; Amin, Hesham M; Kaseb, Ahmed Omar.
Affiliation
  • Chamseddine S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, schamseddine@mdanderson.org.
  • Mohamed YI; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lee SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yao JC; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hu ZI; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tran Cao HS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Morris JS; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Hatia RI; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hassan M; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Duda DG; Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Diab M; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
  • Mohamed A; Division of Hematology/Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Nassar A; Department of Surgery, Emory University, Atlanta, Georgia, USA.
  • Datar S; Department of Internal Medicine University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Amin HM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kaseb AO; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Oncology ; 101(11): 730-737, 2023.
Article in En | MEDLINE | ID: mdl-37467732
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncology Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncology Year: 2023 Document type: Article